Genacol AminoLock Sequence Technology

Genacol Canada Corporation inc. is proud to announce that it has obtained a Canadian and American patent which establishes the company’s capacity for innovation in joint health.

Indeed, Genacol’s AminoLock Sequence Technology has been recognized as unique and different from other hydrolyzed collagen production methods on the market.

This patent relates more specifically to this enzymatic hydrolysis technology, which results in a collagen hydrolyzate with a very low molecular weight (less than 1000 Daltons) intended to prevent or reduce joint pain associated with osteoarthritis. Once again, Genacol also demonstrates that its joint care supplements not only have clinically proven efficacy, but they are also innovative.

CA Patent Number 2950096  |  US Patent Number 11.040.081

 

Science & innovation at the heart of our priorities

Genacol has always placed science and innovation at the heart of its priorities. We are very proud of this accomplishment; it results from several years of work and investments in research and development. This patent will support our development in Canada and internationally to offer people our natural and effective solutions to take care of their joints.

Martin Vidal,
President and CEO

About Hydrolyzed Collagen

Collagen in its native form is hard to digest and is not optimally absorbed by the body. To consume it as a supplement and facilitate its absorption, collagen protein undergoes a process called “enzymatic hydrolysis” to break down the protein into smaller parts (i.e.., peptides and amino acids), thereby making it more bioavailable. This broken-down collagen is called collagen hydrolysate. The lower the molecular weight, the more bioavailable a collagen hydrolysate.

Collagen is the most abundant structural protein in your body. It is composed of amino acids, which are often referred to as protein “building blocks”. Your body naturally produces collagen. However, as we age, the production of collagen by our body slows down.
A collagen supplement helps to provide key amino acids (i.e., those “building blocks”) necessary for optimal protein production. A collagen supplement also helps to slow the effects of collagen loss by supplying various bioactive peptides, which are just small sequences of amino acids. To learn more about the essential role of collagen on your body read our article in our Health Blog section.

A Patented BioActive Enzymatic Hydrolysis

The average size of commercially available hydrolyzed collagen generally varies between 3 to 10 kilodaltons (kDa). However, Genacol’s patented AminoLock Sequence Technology produces very low molecular weight collagen peptide fragments, weighing less than 1 kilodalton (kDa), making them more likely to be absorbed by our digestive system. Moreover, this exclusive technology enables Genacol to ensure its ultra-hydrolyzed AminoLock Collagen contains well-established bioactive peptides to promote joint health and supplies crucial amino acids needed for collagen production to ensure optimal outcomes.

A Patented BioActive Enzymatic Hydrolysis

The average size of commercially available hydrolyzed collagen generally varies between 3 to 10 kilodaltons (kDa). However, Genacol’s patented AminoLock Sequence Technology produces very low molecular weight collagen peptide fragments, weighing less than 1 kilodalton (kDa), making them more likely to be absorbed by our digestive system. Moreover, this exclusive technology enables Genacol to ensure its ultra-hydrolyzed AminoLock Collagen contains well-established bioactive peptides to promote joint health and supplies crucial amino acids needed for collagen production to ensure optimal outcomes.

 

About Genacol Canada Corporation Inc.

Corporation Genacol Canada Inc. is a leader in developing and marketing natural health products to relieve joint pain associated with osteoarthritis and maintain joint health. Its mission is to improve the quality of life of its customers by offering them a range of innovative natural health products.

Building on its success in Canada, Genacol has also developed a strong international presence with Genacol brand products available in more than 40 countries, including Latin America, Europe, Asia, the Middle East, Africa, and the United States.

Moreover, the Genacol brand is registered in 81 countries worldwide. Its success is based on its ultra-hydrolyzed AminoLock Collagen, manufactured using an exclusive process called “AminoLock Sequence Technology,” which is an ingredient in many Genacol products.

Visit our Clinical studies page to learn more about the science and innovation behind Genacol.

Discover all
our products